Could a simple brace help babies with cerebral palsy?

NCT ID NCT06027580

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a wearable trunk brace, called the SPIO Core-Max Expedition TLSO, can improve head, trunk, and arm function in infants aged 6 to 18 months with cerebral palsy. Thirty infants will wear the brace for 2 hours daily over 6 months, and researchers will measure changes in posture and quality of life compared to standard care. The goal is to see if this device offers practical benefits for daily movement and comfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SPIO Core-Max Expedition TLSO (a wearable trunk brace)
What this could lead to
If it works, this brace could help infants with cerebral palsy gain better head and trunk control, possibly improving their quality of life and daily function.
What could go wrong
This is a small, early-stage study with only 30 infants. The brace may not provide meaningful benefits over standard care, and results may not apply to all children with cerebral palsy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral palsy Muscle Hypotonia Muscle Spasticity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medical College of Wisconsin/Children's Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.